Abstract
SAT114 - Efx treatment improved histopathology and non-invasive markers of liver injury and fibrogenesis to a similar extent in NASH patients with high-risk PNPLA3 genotypes, compared to those with lowest genetic risk: a post-hoc analysis of balanced study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have